Enterococci with reduced susceptibility to vancomycin in New Zealand

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 3, 2000, Pages 405-410

  Kobayashi, Kere ^a   Rao, Min ^a   Keis, Stefanie ^a   Rainey, Frederick A ^b   Smith, John M B ^a   Cook, Gregory M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CLINDAMYCIN; ESCULIN; PIGMENT; RIBOSOME DNA; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; AUTOANALYSIS; AUTOMATION; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CELL MOTILITY; DNA DETERMINATION; DNA SEQUENCE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; FECES ANALYSIS; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; NEW ZEALAND; NONHUMAN; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; STRAIN DIFFERENCE;

EID: 0033824874     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/46.3.405     Document Type: Article

References (38)

1. Vancomycin-resistant enterococci
2. Vancomycin-resistant enterococci outside the health-care setting: Prevalence, sources, and public health implications
3. Vancomycin-resistant enterococci
4. Genetics and mechanisms of glycopeptide resistance in enterococci
5. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405
6. VanD-type glycopeptide-resistant Enterococcus faecium BM4339
7. Susceptibility patterns of bacterial isolates from intensive care and haematology/oncology patients in New Zealand
8. Surveillance for antimicrobial resistance in enterococci
9. Vancomycin resistant enterococci in New Zealand
10. Identification of enterococcus species isolated from human infections by a conventional test scheme
11. Screening of stool samples for identification of vancomycin-resistant Enterococcus isolates should include the methyl-alpha-D-glucopyranoside test to differentiate nonmotile Enterococcus gallinarum from E. faecium
12. Detection and differentiation of vanC-1, vanC-2, and vanC-3 glycopeptide resistance genes in enterococci
13. The genus Nocardiopsis represents a phylo-genetically coherent taxon and a distinct actinomycete lineage: Proposal of Nocardiopsaceae fam. nov
14. Taxonomy and phylogeny of industrial solvent-producing clostridia
15. Vancomycin resistance gene vanC is specific to enterococcus gallinarum
16. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci
17. Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolates
18. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
19. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States
20. Antimicrobial-resistant pathogens in the 1990s
21. Glycopeptide-resistant enterococci: A decade of experience
22. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection
23. The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
24. Historical yearly usage of vancomycin
25. Vancomycin-resistant Enterococcus faecium colonization in children
26. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infections in man
27. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms
28. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms
29. Glycopeptide-resistant enterococci isolated from uncooked meat
30. Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans?
31. Vancomycin resistance: Time to ban avoparcin?
32. Commission Directive 97/6/EC of 30 January 1997 amending Council Directive 70/524/EEC concerning additives in feed stuffs
33. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalised patients
34. Comparison of simple and rapid methods for identifying enterococci intrinsically resistant to vancomycin
35. Characterization of yellow-pigmented enterococci from severe human infections
36. Vancomycin susceptibility and identification of motile enterococci
37. Characterization of glycopeptide-resistant enterococci from a Swiss hospital
38. Emergence of vancomycin-resistant enterococci in Australia: Phenotypic and genotypic characteristics of isolates